JW Holdings, Chong Kun Dang, Boryung Pharm, and BC World Pharm have signed agreements totaling approximately KRW 200 billion with Sudair Pharmaceutical to export products to Saudi Arabia over the next five years.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,160 KRW | +0.33% | -0.32% | -4.64% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,200 KRW | +0.72% | +0.27% | 548M | ||
3,010 KRW | 0.00% | +0.17% | 161M | ||
1st Jan change | Capi. | |
---|---|---|
-4.64% | 38.47M | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.22% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- A200780 Stock
- News BCWORLD PHARM. Co., Ltd.
- JW Holdings, Chong Kun Dang, Boryung Pharm, and BC World Pharm Sign KRW 200 Billion Agreement with Sudair Pharmaceutical to Export Products to Saudi Arabia Over the Next Five Years